(Q37774541)

23 August 2017

Type 2 diabetes and obesity in adults (English)

1 reference

23 August 2017

0 references

0 references

Catherine Whitmore

1

1 reference

23 August 2017

1 July 2010

1 reference

British Journal of Nursing

23 August 2017

1 reference

23 August 2017

19

1 reference

23 August 2017

14

1 reference

23 August 2017

880, 882-6

1 reference

The case for low carbohydrate diets in diabetes management

23 August 2017

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

The effects of intensive glycaemic control on body composition in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Long-term effects of advice to consume a high-protein, low-fat diet, rather than a conventional weight-loss diet, in obese adults with type 2 diabetes: one-year follow-up of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Utility of a short-term 25% carbohydrate diet on improving glycemic control in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the Ameri

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

A high-protein low-fat diet is more effective in improving blood pressure and triglycerides in calorie-restricted obese individuals with newly diagnosed type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Randomised controlled trial of four commercial weight loss programmes in the UK: initial findings from the BBC "diet trials"

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2010.19.14.49041

10.12968/BJON.2010.19.14.49041

21 January 2018

Identifiers

DOI

0 references

PubMed ID

20647979

1 reference

PubMed ID

20647979